During the last 12 months, the RCN Rheumatology Forum (RCNRF) has held two strategy meetings: one on 20 March 2018 and (a self-funded one) on the 28 November 2019, during which the following items were discussed and agreed.
Review of RCNRF publication:
The agreed projects for 2019/2020 include review of:
- 2017 (4th edition) of the RCN Biologics guidance document for Rheumatology Practitioners – “Assessing, managing and monitoring Biologic therapies for Inflammatory Arthritis”
- 2016 (3rd edition) of the RCN Administration of subcutaneous Methotrexate guidance document.
Read more of this article